Day: May 3, 2023

MCLEAN, Va., May 03, 2023 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its First Quarter 2023 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q and earnings press release, along with the First Quarter 2023 financial results supplement are available now on the Investor Relations page of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, May 3, 2023, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout all economic cycles....

Announcement no. 8-2023 3 May 2023 North Media CEO Lasse Ingemann Brodt commented on the results for Q1 2023:“Our Q1 2023 results were in line with expectations. Once again, BoligPortal delivers record-high revenue and EBIT, driven by a large number of rental units listed, while our other three businesses, and FK Distribution in particular, reported reduced activity levels. We continued to develop our businesses in order to capitalise even more on volume and scale benefits, while staying focused on establishing the future strategic platform for the entire Group.”         Financial highlights:DKKm Q1  2023 2022Revenue 240.0 248.2EBIT 43.8 48.2EBIT margin 18.3% 19.4%Return on securities 103.8 -94.9Cash flows from operating activities 57.0 37.0Free cash flow 53.6 35.1Performance by business area – Q1 2023 The Last...

LONDON, May 03, 2023 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a global leader in quantum encryption technology, announced it will report financial results for the six months ending March 31, 2023 on Wednesday, May 17, 2023. In conjunction with this announcement, Arqit will host a conference call at 11:00 a.m. ET / 8:00 a.m. PT on May 17, 2023 with the Company’s Founder, Chairman and CEO, David Williams, and CFO, Nick Pointon. A live webcast of the call will be available on the “News & Events” page of the Company’s website at ir.arqit.uk. To access the call by phone, please go to this link (registration link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be...

— EXPAREL continues to outperform elective surgery market with average daily volumes up 6 percent over prior year — — Conference call today at 8:30 a.m. ET — TAMPA, Fla., May 03, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2023. First Quarter 2023 Financial HighlightsTotal revenues of $160.3 million Net product sales of $130.4 million for EXPAREL, $24.3 million for ZILRETTA, and $4.0 million for iovera° Net loss of $19.5 million, or $0.43 per share (basic and diluted) Adjusted EBITDA of $41.9 million“2023 is off to a positive start as EXPAREL continues to outperform the elective surgery market with expanding utilization across...

Key Q1 2023 HighlightsRevenue and Adj. Revenue(1): $922M Pre-tax Income (Loss): $(8)M Adj. EBITDA Margin(1): 9.8% New business signings ACV(2): $125M Net ARR Activity Metric(2) (TTM): $108MFLORHAM PARK, N.J., May 03, 2023 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions company, today announced its first quarter 2023 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q1 Revenue and EBITDA met expectations. This performance is another proof point of our continued momentum and ability to execute with predictable outcomes. Q1 sales, as expected, were lower year-over-year for the quarter due to several large deals that are now expected to manifest in Q2 and beyond, including large contracts, specifically in the public sector. Our pipeline is strong...

Emerging leader in RNA medicines with multi-modal discovery and development platform and first-in-class RNA editing programs Rapidly advancing toward 2023 CTA submissions and first-in-human study for WVE-006, the industry’s first RNA editing clinical candidate Planning for potentially registrational Phase 2 clinical study for WVE-N531 to assess functional dystrophin protein restoration in DMD patients, following best-in-class exon-skipping data reported in December 2022 Preparing broad suite of first- and best-in-class medicines enabled by multi-modal RNA medicine platform and proprietary genetic insights from GSK collaboration; investor event anticipated in 3Q 2023 Cash and cash equivalents of $207.6 million as of March 31, 2023, with runway expected into 2025, plus potential milestone payments from GSK collaboration in 2023 and beyond Investor...

First Quarter 2023 ResultsAll amounts expressed in US dollars TORONTO, May 03, 2023 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) — The completion of major processing plant maintenance at Nevada Gold Mines, the conversion of the Goldstrike autoclave to a carbon-in-leach process, a much-improved performance from Turquoise Ridge and the steady ramp-up of throughput at Pueblo Viejo’s expanded plant will boost production in the second half of the year and keep Barrick on track to achieve its 2023 guidance, the company said today. Reporting on the results for the first quarter, president and chief executive Mark Bristow said production, while lower than Q4 2022, was on plan, and free cash flow1 had still increased, demonstrating the value of Barrick’s Tier One2 asset portfolio. Net earnings per share for the quarter...

VIRGINIA CITY, Nev., May 03, 2023 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), an innovator of technologies that enable systemic decarbonization, today announced its recent Q1 2023 operational highlights. “Over the past three months, we monetized non-strategic assets and positioned ourselves to meet or exceed our $30 million target this year. We have also advanced our fuels, metals, and mining lines of business, and GenMat, our strategic investee, announced a customer demonstration of their physics-based general artificial intelligence capabilities. We are excited that all of this drives our commercializations,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. Selected Strategic Highlights from the First Quarter 2023 Comstock Fuels “Our fuels team is unblocking...